United States · Biotechnology Research
Research
Pharmaceuticals
Biotechnology
Healthcare
Biotechnology Research
Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com.
2006
Founded
Biotechnology Research
Industry
United States
Location
1,762,353
Ranking
97 employees
Size

Get full access to view complete information
